selected scholarly activity
-
academic article
- Persistent hematopoietic polyclonality after lentivirus-mediated gene therapy for Fabry disease. Molecular Therapy - Methods and Clinical Development. 28:262-271. 2023
- What do hematology residents know about caring for older adults with cancer? A national survey of Canadian hematology residents' knowledge and interests. Journal of Geriatric Oncology. 13:1236-1240. 2022
- A Prospective Economic Analysis of Early Outcome Data From the Alliance A041202/ CCTG CLC.2 Randomized Phase III Trial Of Bendamustine-Rituximab Compared With Ibrutinib-Based Regimens in Untreated Older Patients With Chronic Lymphocytic Leukemia. Clinical Lymphoma, Myeloma and Leukemia. 21:766-774. 2021
- Bruton’s tyrosine kinase Inhibitors and Cardiotoxicity: More Than Just Atrial Fibrillation. Current Oncology Reports. 23:113. 2021
- Lentivirus-mediated gene therapy for Fabry disease. Nature Communications. 12:1178. 2021
- First-Line Therapy, Autologous Stem-Cell Transplantation, and Post-Transplantation Maintenance in the Management of Newly Diagnosed Mantle Cell Lymphoma. Current Oncology. 27:632-644. 2020
- Long-Term Studies Assessing Outcomes of Ibrutinib Therapy in Patients With Del(11q) Chronic Lymphocytic Leukemia. Clinical Lymphoma, Myeloma and Leukemia. 19:715-722.e6. 2019
- Systemic Exposure of Rituximab Increased by Ibrutinib: Pharmacokinetic Results and Modeling Based on the HELIOS Trial. Pharmaceutical Research. 36:93. 2019
- Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma. Leukemia. 33:969-980. 2019
- Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis. British Journal of Haematology. 184:558-569. 2019
- Canadian Evidence-Based Guideline for the First-Line Treatment of Chronic Lymphocytic Leukemia. Current Oncology. 25:461-474. 2018
- Safety Analysis of Four Randomized Controlled Studies of Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Mantle Cell Lymphoma. Clinical Lymphoma, Myeloma and Leukemia. 18:648-657.e15. 2018
- Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials. Hematology Journal. 102:1796-1805. 2017
- Age constraints on the hydrothermal history of the Prominent Hill iron oxide copper-gold deposit, South Australia. Mineralium Deposita: international journal of geology, mineralogy, and geochemistry of mineral deposits. 52:863-881. 2017
- The CDK inhibitor AT7519M in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) and mantle cell lymphoma. A Phase II study of the Canadian Cancer Trials Group. Leukemia and Lymphoma. 58:1358-1365. 2017
- Current understanding of bleeding with ibrutinib use: a systematic review and meta-analysis. Blood Advances. 1:772-778. 2017
- Examining the Medical Resource Utilization and Costs of Relapsed and Refractory Chronic Lymphocytic Leukemia in Ontario. Current Oncology. 24:50-54. 2017
- Follow-Up Care for Survivors of Lymphoma Who Have Received Curative-Intent Treatment. Current Oncology. 23:499-513. 2016
- Multiple Myeloma Mortality in Relation to Obesity Among African Americans. Journal of the National Cancer Institute. 108:djw120-djw120. 2016
- The risk of atrial fibrillation with ibrutinib use: a systematic review and meta-analysis. Blood. 128:138-140. 2016
- Safety and efficacy of different lenalidomide starting doses in patients with relapsed or refractory chronic lymphocytic leukemia: results of an international multicenter double-blinded randomized phase II trial*. Leukemia and Lymphoma. 57:1291-1299. 2016
- Accrual of Adolescents and Young Adults with Cancer to Clinical Trials. Current Oncology. 23:81-85. 2016
- Lenalidomide treatment and prognostic markers in relapsed or refractory chronic lymphocytic leukemia: data from the prospective, multicenter phase-II CLL-009 trial. Blood Cancer Journal. 6:e404-e404. 2016
- Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study. The Lancet Oncology. 17:200-211. 2016
- Alemtuzumab and CHOP Chemotherapy for the Treatment of Aggressive Histology Peripheral T Cell Lymphomas: A Multi-Center Phase I Study. Clinical Lymphoma, Myeloma and Leukemia. 16:18-28.e4. 2016
- Are strict vegetarians protected against prostate cancer?. American Journal of Clinical Nutrition. 103:153-160. 2016
- Central adiposity, obesity during early adulthood, and pancreatic cancer mortality in a pooled analysis of cohort studies. Annals of Oncology. 26:2257-2266. 2015
- A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed ch. British Journal of Haematology. 167:466-477. 2014
- Identifying the supportive care needs of adolescent and young adult survivors of cancer: a qualitative analysis and systematic literature review. Supportive Care in Cancer. 22:947-959. 2014
- Vegetarian Diets and the Incidence of Cancer in a Low-risk Population. Cancer Epidemiology, Biomarkers and Prevention. 22:286-294. 2013
- Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. The Lancet Oncology. 13:1141-1151. 2012
- Association between dietary fiber and incident cases of colon polyps: the adventist health study.. Gastrointestinal Cancer Research. 4:161-167. 2011
- Foods and Food Groups Associated With the Incidence of Colorectal Polyps: The Adventist Health Study. Nutrition and Cancer: an international journal. 63:565-572. 2011
- Principles and Recommendations for the Provision of Healthcare in Canada to Adolescent and Young Adult–Aged Cancer Patients and Survivors. Journal of Adolescent and Young Adult Oncology. 1:53-59. 2011
- Lack of Comprehension of Common Prostate Cancer Terms in an Underserved Population. Journal of Clinical Oncology. 27:2015-2021. 2009
- Still No Meta-Analysis of Screening Colonoscopy for Colorectal Cancer? Reply. Digestive Diseases and Sciences. 54:697-697. 2009
- Screening Colonoscopy for Colorectal Cancer in Asymptomatic People: A Meta-Analysis. Digestive Diseases and Sciences. 53:3049-3054. 2008
- Family Interactions Among African American Prostate Cancer Survivors. Family and Community Health. 31:213-220. 2008
- Biomarkers and the design of clinical trials in cancer. Biomarkers in Medicine. 1:387-397. 2007
- Alemtuzumab in Chronic Lymphocytic Leukemia. Current Oncology. 14:96-109. 2007
- Complementary and Alternative Medicine Modality Use and Beliefs Among African American Prostate Cancer Survivors. Oncology Nursing Forum. 34:359-364. 2007
- [Colonoscopy for early detection of colorectal cancer in average-risk population].. Harefuah. 145:841-842. 2006
- Dietary Risk Factors for Ovarian Cancer: The Adventist Health Study (United States). Cancer Causes and Control. 17:137-146. 2006
- Generation ofin vitroB-CLL specific HLA class I restricted CTL responses using autologous dendritic cells pulsed with necrotictumor lysate. Leukemia and Lymphoma. 47:297-306. 2006
- Locally advanced breast cancer in octogenarian women. Breast Cancer Research and Treatment. 89:81-90. 2005
- Nutrition and Physical Activity and Chronic Disease Prevention: Research Strategies and Recommendations. Journal of the National Cancer Institute. 96:1276-1287. 2004
- Cytomegalovirus prophylaxis and treatment after hematopoietic stem cell transplantation in Canada: a description of current practices and comparison with Centers for Disease Control/Infectious Diseases Society of America/American Society for Blood and Marrow Transplantation guideline recommendations. Biology of Blood and Marrow Transplantation. 10:287-297. 2004
- Case-control study of screening colonoscopy in relatives of patients with colorectal cancer. American Journal of Gastroenterology. 98:486-489. 2003
- Case-control study of screening colonoscopy in relatives of patients with colorectal cancer. American Journal of Gastroenterology. 98:486-489. 2003
- Alcohol, tobacco and breast cancer – collaborative reanalysis of individual data from 53 epidemiological studies, including 58 515 women with breast cancer and 95 067 women without the disease. British Journal of Cancer. 87:1234-1245. 2002
- Protective effect of faecal occult blood test screening for colorectal cancer: worse prognosis for screening refusers. Gut. 50:33-37. 2002
- Pooled Analysis of Prospective Cohort Studies on Height, Weight, and Breast Cancer Risk. American Journal of Epidemiology. 152:514-527. 2000
- Extraosseous Osteosarcoma of the Penis. Clinical Oncology. 12:238-239. 2000
- Extraosseous Osteosarcoma of the Penis. Clinical Oncology. 12:238-239. 2000
- Long-term survival following extra-neural metastasis from a pineoblastoma.. Journal of Neuro-Oncology. 48:141-144. 2000
- Mothers and daughters from breast cancer families: a qualitative study of their perceptions of risks and benefits associated with minor's participation in genetic susceptibility research.. Journal of the American Medical Women's Association. 55:280-293. 2000
- Metastatic Breast Cancer Presenting as Tolosa–Hunt Syndrome. Clinical Oncology. 11:407-409. 1999
- In colorectal carcinoma patients, serum vitamin D levels vary according to stage of the carcinoma. Cancer. 86:391-397. 1999
- Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer. The Lancet. 350:1047-1059. 1997
- Breast cancer and hormonal contraceptives: Further results. Contraception. 54:S1-S106. 1996
- Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. The Lancet. 347:1713-1727. 1996
- Occupational physical activity and risk of cancer of the colon and rectum in New Zealand males. Cancer Causes and Control. 4:45-50. 1993
-
conference paper
- Final 5-year findings from the phase 3 HELIOS study of ibrutinib plus bendamustine and rituximab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma. Leukemia and Lymphoma. 3188-3197. 2020
- Ibrutinib (I) plus bendamustine and rituximab (BR) in previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): a 2-year follow-up of the HELIOS study. Oncology Research and Treatment. 34-35. 2017
- 11q Deletion (del11q) Is Not a Prognostic Factor for Adverse Outcomes for Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Treated with Ibrutinib: Pooled Data from 3 Randomized Phase 3 Studies. Blood. 2042-2042. 2016
- Systemic Exposure of Rituximab Increased By Ibrutinib: Pharmacokinetic Results from the Helios Trial. Blood. 4403-4403. 2016
- Ibrutinib (I) plus bendamustine and rituximab (BR) in previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): a 2-year follow-up of the HELIOS study. Oncology Research and Treatment. 34-35. 2016
- IBRUTINIB PLUS BENDAMUSTINE AND RITUXIMAB IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL): 2-YEAR FOLLOW-UP INCLUDING MRD FROM THE HELIOS STUDY. Haematologica: the hematology journal. 150-151. 2016
- Ibrutinib (I) plus bendamustine and rituximab (BR) in previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): a 2-year follow-up of the HELIOS study.. Journal of Clinical Oncology. 7525-7525. 2016
- Comparing Single-Agent Ibrutinib, Bendamustine Plus Rituximab (BR) and Ibrutinib Plus BR in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): An Indirect Comparison of the RESONATE and HELIOS Trials. Blood. 2944-2944. 2015
- Ibrutinib Plus Bendamustine/Rituximab (BR) Is Associated with Greater Reductions in Fatigue Than Placebo Plus BR Among Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia and Fatigue. Blood. 2015
- Impact of High Risk Prognostic Parameters and Addition of Ibrutinib to Bendamustine/Rituximab (BR) on Outcomes for Patients with Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) from the Phase 3 Double-Blind HELIOS Trial. Blood. 2015
- Improvement of Quality of Response with Ibrutinib Plus Bendamustine/Rituximab Vs Placebo Plus Bendamustine/Rituximab for Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL). Blood. 2938-2938. 2015
- Insights into the Management of Adverse Events in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Experience from the Phase 3 HELIOS Study of Ibrutinib Combined with Bendamustine/Rituximab. Blood. 2936-2936. 2015
- Ibrutinib combined with bendamustine/rituximab (BR) in previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): safety analysis in the HELIOS trial. Leukemia and Lymphoma. 93-94. 2015
- Ibrutinib combined with bendamustine/rituximab (BR) in previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): subgroup efficacy analyses from the HELIOS trial. Leukemia and Lymphoma. 98-100. 2015
- Ibrutinib combined with bendamustine/rituximab (BR) in previously treated small lymphocytic lymphoma (SLL): analysis of patients in the HELIOS trial. Leukemia and Lymphoma. 92-93. 2015
- Ibrutinib combined with bendamustine and rituximab (BR) in previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): First results from a randomized, double-blind, placebo-controlled, phase III study.. Journal of Clinical Oncology. LBA7005-LBA7005. 2015
- IBRUTINIB COMBINED WITH BENDAMUSTINE/RITUXIMAB IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL): FIRST RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PHASE 3 STUDY. Haematologica: the hematology journal. 55-56. 2015
- Intake of Soy Isoflavones Reduces Breast Cancer Incidence among Women in North America. The FASEB Journal. 2015
- A Phase II Study of AT7519M, a CDK Inhibitor, in Patients with Chronic Lymphocytic Leukemia: NCIC CTG Trial IND.193. Blood. 2014
- A phase 1 multicenter clinical trial of alemtuzumab and CHOP chemotherapy for peripheral T-cell lymphomas.. Journal of Clinical Oncology. 8551-8551. 2014
- Health Care Resource Utilization in the Management of Chronic Lymphocytic Leukemia at an Ontario Cancer Centre. Value in Health. A79-A79. 2014
- TP53 Mutation or Deletion and Efficacy with Single-Agent Lenalidomide in Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) (CC-5013-CLL-009 Study). Blood. 1638-1638. 2013
- VEGETARIAN DIETARY PATTERNS ASSOCIATED WITH BIOMARKERS OF CANCER RISK. American Journal of Epidemiology. S110-S110. 2013
- Characteristics of clinical trials for adolescent and young adult (AYA) cancer patients (pts) in Ontario.. Journal of Clinical Oncology. 2013
- IDENTIFYING THE HEALTH AND SUPPORTIVE CARE NEEDS OF ADOLESCENT AND YOUNG ADULT CANCER PATIENTS AND SURVIVORS. Pediatric Blood and Cancer. 1119-1119. 2012
- Comparison of Comorbidity Scores and the Impact of Comorbidities on Length of Stay and Survival in Patients with Non-Hodgkin's Lymphoma Treated with Autologous Stem Cell Transplant. Blood. 917-917. 2011
- Interim Results for the Safety and Efficacy of Different Lenalidomide Starting Dose Regimens in Subjects with Relapsed or Refractory Chronic Lymphocytic Leukemia (CC-5013-CLL-009 Study). Blood. 1233-1233. 2011
- Identifying the Health Care Supportive needs of Adolescents and Young Adult Cancer Patients and Survivors: Preliminary Findings from a Qualitative Study. International Journal of Qualitative Methods. 481-482. 2011
- INITIAL OUTCOME DATA FROM SCOTTISH BOWEL SCREENING PROGRAMME. Annals of Oncology. I20-I20. 2010
- Empiric Antifungal Therapy with Amphotericin B in the Era of Fluconazole Prophylaxis: a Cohort Study in Adults with Acute Myeloid Leukemia Treated within An Institutional Antifungal Policy. Blood. 566-566. 2009
- Determining Patterns of Therapy Choice in Patients Treated for Early Stage, Aggressive Histology Non-Hodgkin's Lymphoma. International Journal of Radiation: Oncology - Biology - Physics. S484-S485. 2009
- 17 DETERMINING PATTERNS OF THERAPY CHOICE IN PATIENTS TREATED FOR EARLY STAGE, AGGRESSIVE HISTOLOGY NONHODGKIN'S LYMPHOMA. Radiotherapy and Oncology. S6-S6. 2009
- Large-Scale Production of Autologous CD14+-Monocyte Derived Dendritic Cells Co-Electroporated with Amplified Total Tumour mRNA and Human CD40L mRNA in Patients with B-Cell Chronic Lymphocytic Leukemia.. Blood. 3720-3720. 2006
- Misunderstanding of prostate cancer (CaP) among African American (AA) men of lower socioeconomic status (Lo-SES).. Journal of Clinical Oncology. 329S-329S. 2006
- The Effect of Prophylactic Administration of Myeloid Growth Factors Following Autologous Stem Cell Transplantation for Patients with Hematological Malignancies: A Systematic Review.. Blood. 2192-2192. 2004
- The Use of Aprotinin to Reduce Transfusion Requirements in Children Undergoing Cardiac Surgery: A Meta-Analysis.. Blood. 2718-2718. 2004
- Induction of specific immunity to B-CLL cells by in vitro stimulation using antigen pulsed autologous dendritic cells.. Blood. 439A-439A. 2003
- The ability to harvest increased numbers of peripheral blood progenitor cells is a predictor of improved overall survival in patients with multiple myeloma treated by autologous hematopoietic stem cell transplantation. Blood. 983A-983A. 2003
- A case-control study of screening colonoscopy in relatives of colorectal cancer patients. Gastroenterology. A484-A484. 2002
- Diet and risk of fatal ovarian cancer among Seventh-day Adventists women. The Adventists health study.. American Journal of Epidemiology. S197-S197. 2001
- Information needs of women at risk for hereditary breast cancer.. American Journal of Human Genetics. 206-206. 2000
- Attitudes about hereditary breast cancer among diverse breast cancer survivors.. American Journal of Human Genetics. A82-A82. 1999
- Effect of nutritional and clinical factors on serum prostate specific antigen and prostate cancer in a population of elderly California men. American Journal of Clinical Nutrition. 623S-623S. 1999
- Protective effect of fecal occult blood test screening for colorectal cancer: Worse prognosis for screening refusers. Gastroenterology. A655-A655. 1998
- Vitamin D serum levels in different Dukes' stages of colorectal cancer. Gut. A249-A249. 1997
- Colorectal cancer in the south of Israel: Comparison of the clinical characteristics and survival of two periods, 1981-2 and 1986-7.. Gastroenterology. A600-A600. 1997
- Sodium butyrate induces retinoblastoma protein dephosphorylation, p16 expression and growth arrest of colon cancer cells. Gastroenterology. A591-A591. 1996
- DOES THE ADDITION OF CHEMOTHERAPY TO RADIOTHERAPY IMPROVE SURVIVAL IN ADVANCED HEAD AND NECK-CANCER. Clinical Otolaryngology. 284-284. 1982